HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer
2 clinical trials · Condition
◉ Watch HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study (NCT06805812) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2023-05-01 |
| Treatment of Canadian Men and Pre/Peri/Post-menopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy (NCT02753686) | Novartis Pharmaceuticals | 2016-03-15 |
Track HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.